IMCRImmunocore Holdings plc American Depositary Shares

ADRCNasdaq (XNAS)·USD

Identity

Security key: 17031
Ticker: IMCR
Type: ADRC — American Depository Receipt Common
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2021-02-05
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: IMCR

Detail

Enriched 2026-08-14 20:47

Market cap: $1,767,070,040.76
Shares outstanding (class): 50,865,574
Shares outstanding (weighted): 50,865,574
SIC: 2836 BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees: 524
Location: OXFORDSHIRE, X0
Homepage: https://www.immunocore.com
Description: Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

Market cap and share counts drift.

Funds holding this security

33 funds · 38 positions · $153.83M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD CAPITAL OPPORTUNITY FUND VANGUARD HORIZON FUNDS	—	$73.13M	0.30%	2,425,650 NS	FIGI
T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC.	—	$19.40M	0.18%	643,368 NS	FIGI
T. Rowe Price Small-Cap Stock Fund, Inc. T. ROWE PRICE SMALL-CAP STOCK FUND, INC.	—	$14.02M	0.17%	465,030 NS	FIGI
T. Rowe Price Small-Cap Value Fund, Inc. T. ROWE PRICE SMALL-CAP VALUE FUND, INC.	—	$8.93M	0.10%	296,284 NS	FIGI
iShares Biotechnology ETF iShares Trust	IBB	$8.36M	0.10%	277,185 NS	FIGI
T. Rowe Price Institutional Small-Cap Stock Fund T. Rowe Price Equity Funds, Inc.	—	$7.98M	0.18%	264,520 NS	FIGI
MFS New Discovery Series MFS VARIABLE INSURANCE TRUST	—	$3.08M	0.43%	102,016 NS	FIGI
VIP Health Care Portfolio Variable Insurance Products Fund IV	—	$2.53M	0.25%	84,000 NS	FIGI
abrdn Healthcare Investors —	—	$2.02M	0.18%	66,916 NS	FIGI
State Street(R) SPDR(R) Portfolio Developed Wor… SPDR INDEX SHARES FUNDS	SPDW	$1.92M	0.01%	63,806 NS	FIGI
HUSSMAN STRATEGIC MARKET CYCLE FUND Hussman Investment Trust	—	$1.81M	0.46%	60,000 NS	FIGI
abrdn Life Sciences Investors —	—	$1.51M	0.27%	49,941 NS	FIGI
T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC.	—	$1.18M	0.18%	39,016 NS	FIGI
BlackRock Health Sciences Term Trust —	—	$1.12M	0.11%	37,226 NS	FIGI
State Street(R) SPDR(R) S&P(R) International Sm… SPDR INDEX SHARES FUNDS	GWX	$1.02M	0.13%	33,934 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERIMCR
FIGI_COMPOSITEBBG00YYCXFB9
FIGI_SHARE_CLASSBBG00YYCXG54
CIK0001671927
ISINUS45258D1054
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Biotechnology
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Immunocore is a biopharmaceutical company focused on T cell receptor-based immunotherapies, fitting the biotechnology industry under healthcare.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.